Description:

NSABP Protocol B-35 Radiation Therapy Report NCT00053898 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A01A1AE7-8AF7-36F3-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A01A1AE7-8AF7-36F3-E034-080020C9C0E0

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 5/22/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP Protocol B-35 Radiation Therapy Report NCT00053898

Form E1 (04-30-2002) Breast radiation is required on this protocol. Submit form when radiation therapy has ended. If breast radiation was not done, submit form within 90 days of randomization.

Header Module
Are data amended? (If Yes, circle the amended items in red.)
adjuvante radiatio status
Has the patient received adjuvant RT? (prior to treatment failure or second primary cancer)
Was the patient enrolled in NSABP Protocol B-39/RTOG 0413?
Breast
Breast Irradiated
Energy Type (if applicable)
Operative Area Boost
Operative Area Boost